Explore articles tagged with European Expansion
HRV Pharma's acquisition of Germany-based Phatebo GmbH provides an established entry into the European pharmaceutical market. With German pharmaceutical wholesale authorisation, good distribution practice systems and an existing global customer base, the acquisition supports HRV's expansion into finished formulations while strengthening its international presence.
HRV Pharma has entered the European finished formulations market through its acquisition of Germany-based Phatebo. The move gives HRV an established pharmaceutical business with wholesale authorisation, good distribution practice systems and an existing customer base, complementing its global API portfolio.